Oncternal Therapeutics, Inc.
ONCT
Revenue
494.00k
▼-307.00k▼-38.33%
3 Months ChangeAssets
15.60M
▼-8.26M▼-34.61%
3 Months ChangeLiabilities
6.45M
▼-1.65M▼-20.38%
3 Months ChangeFree Cash Flow
-4.78M
▲3.31M▲40.88%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-12
Form 8-K
ID: 0000950170-24-105987
2024-08-08
Form 10-Q
ID: 0000950170-24-094082
2024-08-08
Form 8-K
ID: 0000950170-24-093953
2024-06-21
Form 8-K
ID: 0000950170-24-076218
2024-05-09
Form 10-Q
ID: 0000950170-24-057008
2024-05-09
Form 8-K
ID: 0000950170-24-056882
2024-03-07
Form 8-K
ID: 0000950170-24-027948
2024-01-23
Form 8-K
ID: 0000950170-24-006493
2024-01-05
Form 8-K
ID: 0000950170-24-002434
2023-11-09
Form 10-Q
ID: 0000950170-23-062132